Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
April 30, 1999
Study Completion Date
March 31, 2002
Conditions
Recurrent Colon CancerLiver MetastasesStage IV Rectal CancerRecurrent Rectal CancerStage IV Colon Cancer
Interventions
DRUG
floxuridine
DRUG
leucovorin calcium
DRUG
melphalan
Trial Locations (1)
20892
Surgery Branch, Bethesda
All Listed Sponsors
lead
National Institutes of Health Clinical Center (CC)